Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Given Insider Profile
4 Followers
Douglas Given, Director at Arrowhead Pharmaceuticals, holds 129.71K shares in Arrowhead Pharmaceuticals (Ticker: ARWR).
Douglas Given Arrowhead Pharmaceuticals (ARWR)Director
Arrowhead Pharmaceuticals (ARWR)
Director
Ranked #60,407 out of 98,564 Corporate Insiders
Profitable Transactions
7 out of 13 Profitable Transactions
Average Return
-3.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Douglas Given holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 19, 2014 - Aug 19, 2015
Return:+60.90%
The most profitable trade made by Douglas Given
Douglas Given's Trading History
List of latest transactions for each holding click on a transaction to see Douglas Given's performance on stock
You May Also Like
Douglas Given insider profile FAQ
What is the percentage of profitable transactions made by Douglas Given?
The percentage of profitable transactions made by Douglas Given is 54%.
What is the average return per transaction made by Douglas Given?
The average return per transaction made by Douglas Given is -3.40%.
What stocks does Douglas Given hold?
Douglas Given holds: ARWR stocks.
What was Douglas Given’s latest transaction?
Douglas Given latest transaction was an Uninformative Sell of $110.79K.
What was Douglas Given's most profitable transaction?
Douglas Given’s most profitable transaction was an Informative Sell of ARWR stock on August 19, 2014. The return on the trade was 60.90%.
What is Douglas Given's role in Arrowhead Pharmaceuticals?
Douglas Given's role in Arrowhead Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.